DOCN vs NBIX · P/E 75, rev $204.9M vs P/E 45, rev $2.36B
DigitalOcean Holdings Inc (DOCN) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
DigitalOcean Holdings Inc (DOCN) is a software - infrastructure company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DOCN revenue for 2024-12-31 was $204.9M. Net income was $18.3M. Revenue was up 3.2% from 2024-09-30 to 2024-12-31. DOCN currently screens at market cap $17.73B and trailing P/E 74.5.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
DOCN currently screens at market cap $17.73B and trailing P/E 74.5. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the DOCN and NBIX stock pages for the full models.
Not investment advice.